HCB301 is a first-in-class tri-specific immunotherapy targeting SIRPα-CD47, PD-1/PD-L1, and TGFβ; it shows potent macrophage activation, T-cell restoration, and tumor microenvironment remodeling in ...

Axis Securities expects India’s rebound to extend through FY26, driven by GDP growth of 6.8% and steady liquidity. The ...

Electronic Design Today offers up to date coverage of the Electronics Industry. This eNewsletter is delivered five days a ...

New Delhi [India], November 4: Axis Max Life Insurance Limited ("Axis Max Life" / "Company"), formerly known as Max Life Insurance Company Limited, today unveiled the findings of the fifth edition of ...

City planners face the challenge of reconciling the operational needs of urban areas with fundamental principles of society, ...

Still, human data is more nuanced. “While the evidence that the gut microbiome affects mood is relatively strong, evidence ...

A comprehensive review published today in Brain Medicine illuminates the intricate connections between gut microbiota and sleep regulation, establishing the microbiota-gut-brain axis as a critical ...

Keefe Bruyette lowered the firm’s price target on Axis Capital (AXS) to $119 from $125 and keeps an Outperform rating on the shares. Published ...

At the top end of the IPO pricing range, Billionbrains, which counts Microsoft Chief Executive Satya Nadella among its investors, could raise up to 66.32 billion rupees, equivalent to $747.5 million.

Contrary to popular opinion, however, multipolarity is not a death sentence for the United States. In an era of declining relative U.S. power, it benefits Americans to let other capable countries ...

Despite another beat-and-raise quarter for Palantir, the stock’s after-hours reaction was somewhat muted. Check out PLTR's ...